echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > J Clin Med: New study helps protect glare.

    J Clin Med: New study helps protect glare.

    • Last Update: 2020-10-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    SEPTEMBER 19, 2020 /--- In a recent study, researchers at LSU Health's New Orleans Center of Neuroscience Excellence and the University of Copenhagen provided the first evidence that patients with high eye pressure may exhibit superior antioxidant protection, thereby increasing resistance to glare-related elevated intra-eye pressure.
    their findings were published online in journal Clinical Medicine.
    , glare patients are susceptible to elevated eye pressure.
    , despite high intra-eye pressure, some patients still do not have glaminal neurodegeneration.
    (Photo Source: www.pixabay.com) reports on a new mechanism that could explain why patients with high eye pressure do not develop glare.
    this is the first study to assess oxidative stress and antioxidants during oxygen stress in patients with normal stress gla glare and high eye pressure.
    , according to the American 20th Eye Association, high eye pressure refers to situations where in-eye pressure (in-eye pressure or IOP) is higher than normal.
    authors found that patients with high eye pressure had increased antioxidant capacity and higher levels of omega-3-derived anti-inflammatory chemical messengers involved in maintaining plasma cell function than patients with glasoma and age with normal blood pressure.
    these rich omega-3 fatty acid chemical messengers provide antioxidant defenses and, as a result, are potentially resistant to elevated intra-eye pressure and glare neurodegeneration by eliminating increased systemic oxidative stress.
    Nicolas G. Bazan said: "This study opens the way for therapeutic exploration, highlighting the importance of the antioxidant capabilities of the chemical messenger of omega-3 fatty acids as a potential diagnostic biomarker and as a new therapy to prevent neurodegeneration in glare."
    " glare is the most common cause of irreversible blindness.
    although there are currently treatments to reduce in-eye pressure, 15 per cent of glare sufferers are blind in both eyes, with a 42 per cent chance of blindness in one eye.
    (bioon.com) Source: Study finds novel mechanism that may confer protection against glaucoma Original source: Mia Langbøl et al, Increased Antioxidant Capacity Pro-Homeostatic Lipid Mediators in Ocular Hypertension-A Human Human Model, Journal of Medicine (2020). DOI: 10.3390/jcm9092979.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.